Bambuterol Hydrochloride
CAS number： 81732-46-9
Molecular formula： C18H29N3O5.HCl;C18H30ClN3O5
molecular weight： 403.91
Chemical structure：
Producers shown on SFDA
(Record date:12/10/2021）
Producer | Documents | GMP Valid till(based on SFDA) |
| Qilu Pharmaceutical Co., Ltd. | GMP | Valid till October 2022 |
| Hunan Jiudian Pharmaceutical Co., Ltd. | GMP | Valid till May 2024 |
Producers shown on EP
Not showing any
Producer:Qilu Pharmaceutical Co., Ltd. is one of the first batch of GMP certified enterprises by the State Food and drug administration. Among them, non sterile APIs (fermentation, chemical synthesis), sterile APIs and various preparations have passed the certification of the US Food and Drug Administration (USFDA), the European Drug Quality Council (EDQM), the UK MHRA, the South African pharmaceutical Regulatory Commission (MCC) and other national drug regulatory agencies.
Qilu pharmaceutical has seven production bases including preparation, chemical synthesis and biotechnology and antibiotic fermentation, covering an area of 1.9 million square meters. The company's automatic production line and other main production equipment and testing instruments are purchased from major professional pharmaceutical equipment manufacturers in the world.
Registered capital:RMB 60 million
Producer:Hunan Jiudian Pharmaceutical Co., Ltd. is a listed pharmaceutical enterprise integrating drug R & D, production and sales. It was incorporated in 2001 and listed on the gem in 2017.
The company has completed the all-round layout of pharmaceutical preparations, traditional Chinese medicine, APIs, pharmaceutical accessories, pharmaceutical commerce and other industries, established a perfect R & D, marketing and production system, and continuously improved the level of operation and management; R & D resources and market resources are increasingly abundant. It has modern production lines including raw material medicine, oral solid preparation, oral liquid preparation, gel paste, pharmaceutical excipient and so on. Preparations and traditional Chinese medicine are produced in Liuyang Economic Development Zone, APIs and excipients are produced in Wangcheng Economic Development Zone, and R & D and commercial sales are in Changsha high tech Zone.
The company is a R & D driven enterprise with sound R & D system and advanced instruments and equipment. It has more than 10000 square meters of research and development sites, forming a complete test platform from small-scale research to pilot test to industrialization. A 400 person R & D team with doctors, masters and returned overseas talents as the main body has been established, with the strongest R & D level in the province. The company's leading products are self-developed. There are nearly 100 products under research and declared products, which will greatly enrich the company's product pipeline. After the new drugs under research are listed, they will become a heavy variety of existing advantageous products.
Staff size:About 1500 persons
Registered capital:RMB 234 million 700 thousand For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978
Tel: Cell/WhatsApp/WeChat: +86 18402846978
Email: paulzhang@yinuopharmchem.com
SKYPE